Overview
Swedish polymer products maker's Q4 sales slightly missed analyst expectations
Q4 EBITA missed analyst estimates
Company expanding operations in Hungary, Poland, and Malaysia
Outlook
Nolato plans to focus on new materials and technologies for future growth
Company aims for increased profitable growth through organic and acquired expansion
Nolato proposes a dividend of SEK 1.70 per share for 2025
Result Drivers
MEDICAL SOLUTIONS GROWTH - Sales in Medical Solutions increased by 5% adjusted for currency, supported by investments in Hungary, Poland, and Malaysia
ENGINEERED SOLUTIONS CHALLENGES - Sales in Engineered Solutions decreased by 1% adjusted for currency
MATERIALS SEGMENT GROWTH - Materials segment grew by 10% adjusted for currency, driven by higher volumes in network equipment and new products in data centers
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
Slight Miss*
SEK 2.27 bln
SEK 2.28 bln (4 Analysts)
Q4 Net Income
SEK 151 mln
Q4 EBITA
Miss
SEK 236 mln
SEK 263.33 mln (3 Analysts)
Q4 Basic EPS
SEK 0.56
Q4 EBITA Margin
10.40%
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Nolato AB is SEK66.50, about 11.4% above its February 4 closing price of SEK59.70
The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 19 three months ago
Press Release: ID:nMFN9g38k3
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)